Evaxion A (EVAX) Operating Leases (2019 - 2025)
Evaxion A (EVAX) reported Operating Leases of $1.6 million for Q4 2025, down 16.91% on a YoY basis from $1.9 million in Q4 2024, and down 6.13% quarter-over-quarter from $1.7 million in Q2 2025.
Evaxion A (EVAX) Operating Leases (2019 - 2025) Analysis & Trends
Evaxion A has reported Operating Leases for 7 years, with the latest figure at $1.6 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Leases fell 16.91% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (down 16.91% YoY), and the FY2025 full-year result was $1.6 million, down 16.91% from the prior year.
- Operating Leases for Q4 2025 stood at $1.6 million, down from $1.7 million in the prior quarter.
- The five-year high for Operating Leases was $2.5 million in Q4 2021, with the low at $1.6 million in Q4 2025.
- Historically, Operating Leases has averaged $2.0 million across 5 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2021 — Operating Leases soared 12500.0% — and 2025, when it slipped 16.91%.
- Evaxion A's Operating Leases stood at $2.5 million in 2021, then fell by 10.52% to $2.3 million in 2022, then fell by 1.46% to $2.2 million in 2023, then dropped by 12.96% to $1.9 million in 2024, then fell by 16.91% to $1.6 million in 2025.
- The last three Operating Leases figures came in at $1.6 million (Q4 2025), $1.7 million (Q2 2025), and $1.9 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Dec 31, 2022 | 2.26 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Dec 31, 2020 | 20,000.00 |
| Dec 31, 2019 | 36,000.00 |